6RLW

Structure of the human 8-oxoguanine DNA Glycosylase hOGG1 in complex with inhibitor TH5487


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 0.274 
  • R-Value Work: 0.223 

wwPDB Validation   3D Report Full Report


This is version 1.2 of the entry. See complete history


Literature

Targeting OGG1 arrests cancer cell proliferation by inducing replication stress.

Visnes, T.Benitez-Buelga, C.Cazares-Korner, A.Sanjiv, K.Hanna, B.M.F.Mortusewicz, O.Rajagopal, V.Albers, J.J.Hagey, D.W.Bekkhus, T.Eshtad, S.Baquero, J.M.Masuyer, G.Wallner, O.Muller, S.Pham, T.Gokturk, C.Rasti, A.Suman, S.Torres-Ruiz, R.Sarno, A.Wiita, E.Homan, E.J.Karsten, S.Marimuthu, K.Michel, M.Koolmeister, T.Scobie, M.Loseva, O.Almlof, I.Unterlass, J.E.Pettke, A.Bostrom, J.Pandey, M.Gad, H.Herr, P.Jemth, A.S.El Andaloussi, S.Kalderen, C.Rodriguez-Perales, S.Benitez, J.Krokan, H.E.Altun, M.Stenmark, P.Berglund, U.W.Helleday, T.

(2020) Nucleic Acids Res 48: 12234-12251

  • DOI: 10.1093/nar/gkaa1048
  • Primary Citation of Related Structures:  
    6RLW

  • PubMed Abstract: 
  • Altered oncogene expression in cancer cells causes loss of redox homeostasis resulting in oxidative DNA damage, e.g. 8-oxoguanine (8-oxoG), repaired by base excision repair (BER). PARP1 coordinates BER and relies on the upstream 8-oxoguanine-DNA glycosyl ...

    Altered oncogene expression in cancer cells causes loss of redox homeostasis resulting in oxidative DNA damage, e.g. 8-oxoguanine (8-oxoG), repaired by base excision repair (BER). PARP1 coordinates BER and relies on the upstream 8-oxoguanine-DNA glycosylase (OGG1) to recognise and excise 8-oxoG. Here we hypothesize that OGG1 may represent an attractive target to exploit reactive oxygen species (ROS) elevation in cancer. Although OGG1 depletion is well tolerated in non-transformed cells, we report here that OGG1 depletion obstructs A3 T-cell lymphoblastic acute leukemia growth in vitro and in vivo, validating OGG1 as a potential anti-cancer target. In line with this hypothesis, we show that OGG1 inhibitors (OGG1i) target a wide range of cancer cells, with a favourable therapeutic index compared to non-transformed cells. Mechanistically, OGG1i and shRNA depletion cause S-phase DNA damage, replication stress and proliferation arrest or cell death, representing a novel mechanistic approach to target cancer. This study adds OGG1 to the list of BER factors, e.g. PARP1, as potential targets for cancer treatment.


    Organizational Affiliation

    Weston Park Cancer Centre, Department of Oncology and Metabolism, University of Sheffield, Sheffield S10 2RX, UK.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
N-glycosylase/DNA lyase AAABBBCCCDDDEEE337Homo sapiensMutation(s): 0 
Gene Names: OGG1MMHMUTMOGH1
EC: 3.2.2 (PDB Primary Data), 4.2.99.18 (PDB Primary Data)
Find proteins for O15527 (Homo sapiens)
Explore O15527 
Go to UniProtKB:  O15527
NIH Common Fund Data Resources
PHAROS:  O15527
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
K8Q
Query on K8Q

Download Ideal Coordinates CCD File 
AAA, BBB, CCC, DDD, EEE
4-(4-bromanyl-2-oxidanylidene-3~{H}-benzimidazol-1-yl)-~{N}-(4-iodophenyl)piperidine-1-carboxamide
C19 H18 Br I N4 O2
FZLKVWWPFOLPKF-UHFFFAOYSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 0.274 
  • R-Value Work: 0.223 
  • Space Group: P 41 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 86.367α = 90
b = 86.367β = 90
c = 432.4γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
DIALSdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Swedish Research CouncilSweden--

Revision History 

  • Version 1.0: 2020-07-22
    Type: Initial release
  • Version 1.1: 2020-12-02
    Changes: Database references
  • Version 1.2: 2020-12-23
    Changes: Database references